Posted in | News

Institute Focuses on Bioimaging, Bioengineering, Biophysics and Nano-Biotechnology

Waseda University today opened the Waseda Bioscience Research Institute in Singapore (WABIOS) in Biopolis. WABIOS will focus its research in the areas of bioimaging, bioengineering, biophysics and nano-biotechnology. It will also further develop the neuroscience-focused research findings derived from the Waseda-Olympus Bioscience Research Institute – a joint initiative between Waseda University and Olympus Corporation in Biopolis from 2004 – 2009. WABIOS has committed S$2 million for its research activities here and will start with a few researchers from both Japan and Singapore. The establishment of WABIOS is particularly significant in that it marks the first time that Waseda University is setting up research operations overseas independently.

Professor Katsuhiko Shirai, President of Waseda University, and Mr. Lim Chuan Poh, Chairman of the Agency for Science, Technology and Research (A*STAR), signed a Memorandum of Intent (MOI) in Singapore today at the opening of WABIOS. The agreement aims to facilitate research collaborations between scientists from the two organisations through joint symposia and workshops as well as enable graduate students from Waseda University to spend up to 2 years at A*STAR research institutes during the course of their PhD studies under A*STAR’s Research Attachment Programme (A*RAP).

Said Mr. Lim Chuan Poh, Chairman of A*STAR, “I like to congratulate Waseda University in the opening of WABIOS. Waseda’s commitment to its R&D efforts at the Biopolis is an endorsement of Singapore’s vision to building an international hub for scientific R&D. I hope Waseda would be able to tap on the spectrum of research capabilities found at Biopolis and Fusionopolis to build meaningful collaborations and generate impactful outcomes.”

Professor Katsuhiko Shirai, President of Waseda University added, “By setting up our own lab in Biopolis, we will be able to collaborate with world-class researchers in ASTAR, take advantage of cutting edge technology, and explore new academic and research areas. Waseda University has been focusing on doing various research and educational activities in the Asia Pacific region and we found that among countries in the region, Singapore is quite an important place. Singapore has a strong national policy to be an international hub of Biomedical Sciences, and Biopolis is the very central research base in Singapore”.

The establishment of WABIOS in Singapore is a strategic move for Waseda University because it has been promoting internationalisation focused on the Asia-Pacific region. Singapore is well known as a crossroads of knowledge exchange between Japan, China and India and the West. WABIOS will function as a platform for academic exchange between researchers from Waseda University and A*STAR, and in the near future, the institute hopes to establish itself as an academic research centre for all the Japanese research organisations based in Singapore.

WABIOS will function as an overseas institute under the Waseda Institute for Advanced Study (WIAS). It will receive funding through a research grant from Japan’s Ministry of Education, Culture, Sports, Science and Technology (MEXT) disbursed through the Japan Science and Technology Agency (JST). In addition, the institute has plans in the midterm to employ distinguished researchers outside of Japan.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.